Profund Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $971K | Buy |
|
|||||
|
2025
Q2 | $588K | Sell |
|
|||||
|
2025
Q1 | $637K | Sell |
|
|||||
|
2024
Q4 | $782K | Sell |
|
|||||
|
2024
Q3 | $1.03M | Sell |
|
|||||
|
2024
Q2 | $921K | Sell |
|
|||||
|
2024
Q1 | $1.28M | Sell |
|
|||||
|
2023
Q4 | $1.67M | Buy |
|
|||||
|
2023
Q3 | $1.07M | Buy |
|
|||||
|
2023
Q2 | $1.32M | Sell |
|
|||||
|
2023
Q1 | $1.28M | Buy |
|
|||||
|
2022
Q4 | $362K | Buy |
|
|||||
|
2022
Q3 | $316K | Sell |
|
|||||
|
2022
Q2 | $477K | Sell |
|
|||||
|
2022
Q1 | $617K | Sell |
|
|||||
|
2021
Q4 | $788K | Sell |
|
|||||
|
2021
Q3 | $992K | Buy |
|
|||||
|
2021
Q2 | $1.03M | Sell |
|
|||||
|
2021
Q1 | $1.48M | Sell |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $954K | Sell |
|
|||||
|
2020
Q2 | $1.05M | Buy |
|
|||||
|
2020
Q1 | $493K | Sell |
|
|||||
|
2019
Q4 | $670K | Buy |
|
|||||
|
2019
Q3 | $587K | Sell |
|
|||||
|
2019
Q2 | $912K | Sell |
|
|||||
|
2019
Q1 | $1.07M | Buy |
|
|||||
|
2018
Q4 | $607K | Sell |
|
|||||
|
2018
Q3 | $1.32M | Buy |
|
|||||
|
2018
Q2 | $1.2M | Sell |
|
|||||
|
2018
Q1 | $849K | Buy |
|
|||||
|
2017
Q4 | $731K | Sell |
|
|||||
|
2017
Q3 | $930K | Buy |
|
|||||
|
2017
Q2 | $989K | Sell |
|
|||||
|
2017
Q1 | $1.16M | Sell |
|
|||||
|
2016
Q4 | $1.28M | Sell |
|
|||||
|
2016
Q3 | $1.42M | Sell |
|
|||||
|
2016
Q2 | $983K | Sell |
|
|||||
|
2016
Q1 | $1.32M | Sell |
|
|||||
|
2015
Q4 | $2.88M | Buy |
|
|||||
|
2015
Q3 | $2.44M | Buy |
|